Saturday 22 October 2016

This changes blood glucose testing for those with diabetes

Published 18/10/2016 | 10:32

Ascensia Diabetes Care today announced the launch of the CONTOUR®NEXT ONE blood glucose monitoring system (BGMS) in Ireland, one of the next steps in the evolution of self-monitoring of blood glucose.

  • Go To

As part of the system, the CONTOUR®NEXT ONE meter and CONTOUR®DIABETES app seamlessly connect, which makes capturing blood glucose results effortless for people with diabetes. The system enables patterns and trends to be revealed that can help people understand their diabetes, and may help to improve diabetes management.

The meter is now available to residents of Ireland, and you can request it free here.

The system features an easy-to-use wireless-enabled smart meter that links to a smart mobile device via Bluetooth® connectivity. The CONTOUR®NEXT ONE meter gives immediate feedback and also seamlessly connects to the CONTOUR®DIABETES app, which collects, stores and analyses patient blood glucose results received from the meter. The app combines these results with other data recorded by the user, to provide detailed information about their condition that can help them understand how their everyday lives may impact their blood glucose readings, including alerts for critical high or critical low readings. Through the app, meter users can also share with their healthcare professional the reports of their blood glucose results and patterns, either in advance or on the day of their appointment, helping to create more informed discussions. 

“The launch of the CONTOUR®NEXT ONE blood glucose monitoring system in Ireland is the latest of our high quality solutions designed to meet the needs of the diabetes community. By seamlessly capturing data from the meter in the app, this system has the potential to benefit people with diabetes by improving the understanding of their condition and helping them to make more informed decisions about managing their diabetes. We are delighted it is now available to help people with diabetes in Ireland,” explained Grainne O’Connor, Ascensia Diabetes Care.

Request a free CONTOUR®NEXT ONE meter here.

The meter also includes additional features specifically designed to meet patient needs, including the smartLIGHTTM feature that gives instant feedback on blood glucose readings, for better understanding of results. It also has Second-Chance™ sampling, which prompts blood to be reapplied if there is not enough the first time, helping to avoid lancing for a second time and the wasting of strips.

“In the management of diabetes, the accuracy and quality of blood glucose data from an individual is crucial. The CONTOUR®NEXT ONE blood glucose meter has demonstrated consistently remarkable levels of accuracy and precision for patients. There is significant value for doctors and nurses by having easy access to this highly accurate data, which can help to improve how patients are managed,” added Grainne.

Published study data has shown the CONTOUR®NEXT ONE meter to be remarkably accurate1, exceeding EN ISO 15197:2015 accuracy criteria2 in both the laboratory and clinical setting. EN ISO 15197:2015 states that ≥95% of results must be within ± 0.83 mmol/L of the reference result for samples with blood glucose concentrations ˂5.56 mmol/L or ±15% for samples with blood glucose concentrations ≥5.56 mmol/L. Data in the clinical setting showed that 99.4% of readings from subject-obtained fingertip results exceeds EN ISO 15197:2015 accuracy criteria and 95% of readings were shown to be within ±0.47 mmol/L or ±8.4% of the YSI reference results.1

An estimated 225,840 people in Ireland have diabetes.3 The primary goal of diabetes management is to control blood sugar levels and ensure they are kept within a normal range. When blood glucose levels get too high (hypgerlycaemia) or too low (hypoglycaemia), it can lead to serious complications and, in severe cases, even death.

Request a free CONTOUR®NEXT ONE meter here.

The launch of the CONTOUR®NEXT ONE BGMS in Ireland follows CE Mark approval that was recently received, on 17 May 2016. As it is app based, the system is designed to evolve in the future, bringing new capabilities and features to help people with diabetes manage their condition. Those interested in obtaining the CONTOUR®NEXT ONE meter should visit The CONTOUR®DIABETES app is available to download in the Apple App Store (iOS) and Google Play (Android).

Request a free CONTOUR®NEXT ONE meter here.

1 Christiansen et al. Poster presented at the 15th Annual Meeting of the Diabetes Technology Society, October 22-24, 2015, Bethesda, Maryland.

2 International Organization for Standardization (2015). In vitro diagnostic test systems—requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus (EN ISO 15197:2015)

3 Diabetes Ireland accessed October 7th 2016

Sponsored by: CONTOUR®NEXT ONE

Online Editors

Read More

Most Read on Twitter

Most Shared

Latest Commented

Editor's Choice